ElRefai, Mohamed http://orcid.org/0000-0001-8481-1940
Abouelasaad, Mohamed
Menexi, Christina
Morgan, John
Roberts, Paul R.
Article History
Received: 10 February 2022
Accepted: 7 April 2022
First Online: 23 April 2022
Declarations
:
: The study was performed with ethical approval from Health Research Authority (HRA)—REC (20/NW/0366)—and was also granted local research and development (RHMCAR0528) approval.
: All patients gave informed written consent prior to recruitment in the study.
: Dr. Mohamed ElRefai is receiving unrestricted grant from Boston Scientific. Dr. Paul Roberts receives consultancy fees from Boston Scientific and Medtronic. Prof. John Morgan is a senior medical director at Boston Scientific. Other authors have no conflicts of interest to declare.